Schedule 13G ownership disclosure
Zomedica Pharmaceuticals Corp.
Security class unavailable · CUSIP: 98979F107
Event date: 2020-05-26
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 15,487,333
- Percent of class
- 5.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-20-014122
- Form type
- SC 13G
- Filer
- INTRACOASTAL CAPITAL, LLC
- CIK
- CIK 1646799
- Filed
- Jun 04, 2020
- Reporting period
- May 26, 2020
- Description
- Schedule 13G beneficial ownership